Mark Engel is a life sciences entrepreneur. He has founded, built, and sold companies in the specialty pharmaceutical, contract research, and medical supplies sectors.
Currently, Mr. Engel serves as Chairman of two companies. One is a precision biological agriculture firm focusing on antibacterial solutions for crop sciences, food safety, and animal health. The other is a precision biological human health company addressing systemic and topical infections.
In addition to these roles, Mr. Engel manages his family’s investment fund, which directs investments towards the healthcare and agricultural industries.
Mr. Engel holds a law degree from Notre Dame Law School.